Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.7.0 was added to the study's history, and the previous revision v3.6.6 was removed from the history.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry v3.6.6 was added to the history, replacing v3.6.5, reflecting an update to the page's release notes.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page history adds a new revision entry for v3.6.5, replacing the previous v3.6.4, indicating a page metadata update rather than a change to study records.SummaryDifference0.1%

- Check89 days agoChange DetectedA new Revision: v3.6.4 is now listed in the study record history, replacing the previous Revision: v3.6.3. This reflects a minor update to the page interface rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.